Skip to content
Open access

Eosinophil-associated intestinal immune responses following SARS-CoV-2 infection in K18-hACE2 mice

Aug 2026 · PLoS ONE · Vol 21, pp. e0355607 · 0 citations · 40 references
Medicine

TL;DR

Findings indicate that SARS-CoV-2 infection is associated with eosinophil-associated intestinal immune responses in K18-hACE2 mice, and supports virus-associated eosinophil-related intestinal responses as a possible framework for understanding allergy-like intestinal immune alterations during SARS-CoV-2 infection.

Abstract

Background Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is frequently associated with gastrointestinal manifestations; however, intestinal immune responses following SARS-CoV-2 infection remain incompletely understood. This study aimed to characterize eosinophil-associated intestinal immune responses in SARS-CoV-2-infected K18-hACE2 transgenic mice. Methods Small intestinal tissues from infected mice were analyzed using cytokine and chemokine PCR arrays, qRT-PCR, immunohistochemistry, and histological analyses. Results SARS-CoV-2 infection was associated with marked upregulation of Il5 mRNA in small intestinal tissues, along with increased expression of eosinophil-related cytokines and chemokines, including Ccl24 and Ccl11. Immunohistochemical analyses showed eosinophil accumulation in the lamina propria, accompanied by increased signals for eosinophil-associated granule proteins, including major basic protein and eosinophil peroxidase. Additional qRT-PCR analyses showed increased expression of Prg2 and Epx, further supporting eosinophil granule protein-associated responses. Charcot-Leyden crystals and increased Galectin-10 expression were also observed. Temporal analyses showed an acute Il5/Ccl24-related response followed by delayed Ccl11 upregulation during later stages. Conclusions These findings indicate that SARS-CoV-2 infection is associated with eosinophil-associated intestinal immune responses in K18-hACE2 mice. Although eosinophil activation or intestinal allergy was not directly demonstrated, this study supports virus-associated eosinophil-related intestinal responses as a possible framework for understanding allergy-like intestinal immune alterations during SARS-CoV-2 infection.

Read PDF

Similar papers

Open access Sep 2026

Eosinophil-driven immunopathology exacerbates SARS-CoV-2 pneumonia in an OVA-induced airway allergy mouse model

ABSTRACT Asthma is an allergic airway disease characterized by distinct immune environments that can alter host responses to respiratory viral infections; however, its impact on coronavirus disease 2019 (COVID-19) severity remains unclear. To investigate how allergic airway inflammation affects severe acute respiratory...

Takao Iketani, N. Iwata-Yoshikawa, Yusuke Sakai et al. · 0 citations
Sep 2026

A Mouse Model of Coronavirus Disease 2019-Associated Lung Injury Induced by Severe Acute Respiratory Syndrome Coronavirus 2 and Lipopolysaccharide.

Despite the widespread implementation of vaccination and antiviral therapies, SARS-CoV-2 infection continues to cause substantial morbidity and mortality among vulnerable populations, underscoring the urgent need for reliable experimental models to investigate the pathogenesis of COVID-19, elucidate the mechanisms of d...

Ke Liu, Huiping Yang, Wei Zheng et al. · 0 citations
Open access Sep 2026

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily targets the respiratory epithelium, yet severe disease features diffuse lung injury and hyperinflammatory syndromes driven by dysregulated immune activation. Emerging evidence indicates that resident and infiltrating immune cells in the lung can enc...

Yusuke Matsui, R. Suryawanshi, Mauricio Montano et al. · 0 citations
Open access Sep 2026

SARS-CoV-2 spike-armed vesicular stomatitis virus recapitulates severe COVID-19 acute respiratory distress syndrome in mice

Summary Clinically relevant preclinical models are critical for understanding acute respiratory distress syndrome (ARDS) and developing novel therapeutics. Although SARS-CoV-2 pseudovirus-based models overcome biosafety challenges associated with live coronavirus, their ability to recapitulate key ARDS features and res...

Prarthna Karunamurthy, A. Tieu, D. Chwastek et al. · 0 citations
Open access Sep 2026

Allergic Airway Inflammation Protects Against SARS-CoV-2 and MERS-CoV Disease but Promotes Fatal SARS-CoV-1 Immunopathology

Epidemiological, clinical, and experimental data suggest that allergic asthma may have protective effects against severe Coronavirus Disease 2019 (COVID- 19) but are often conflicting between different models of infection and epidemiological analyses. Allergic asthma is characterized by type 2 (T2) inflammation, mucus...

J. Ardanuy, Grace Garrett, C. Dillen et al. · 0 citations
Review Open access 2026

Immune cell interactions and lung damage in SARS-CoV-2 special attention on monocytes/macrophages, T and B lymphocytes, dendritic cells and Toll-like receptors in SARS-CoV-2.

Coronavirus disease 2019 (COVID-19) is caused by a novel human virus - SARS-CoV-2, is characterized in severe cases by dysregulated innate and adaptive immune responses leading to lung injury and systemic hyperinflammation. This review summarizes the roles of monocyte/macrophages, T and B lymphocytes, dendritic cells,...

M. Gulubova, M. Ignatova, Dobromira Nikolaeva Dimitrova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.